Atlas Trials

Chinese Lung Cancer Surgical Group

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Chinese Lung Cancer Surgical Group

RecordFirmDate
Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations (NCT01410214)Chinese Lung Cancer Surgical Group2011-05-01

Track Chinese Lung Cancer Surgical Group automatically

Every clearance here is in the API, with alerts when new ones post.